Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for Placenta Previa and Accreta
NCT02806024Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Nov 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in placenta accreta (PAS) and placenta previa comparing Tranexamic Acid with Placebo (2 arms). Primary endpoint: Estimated Blood Loss. Started Nov 2016; status: completed.
02
Drugs
tranexamic acid
03
Conditions
placenta accreta (PAS)placenta previa
Beyond the preview
Go deeper on NCT02806024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02806024.